81 results
Page 4 of 5
6-K
EX-99
6rv698eoxqhh2kl zv
5 Jun 12
BioLineRx Announces Receipt of Two Notices of
12:00am
424B3
5hrep
28 Mar 12
Prospectus supplement
12:00am
20-F
t7dagm
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
8o01fk0pl2xg6e4
22 Mar 12
BioLineRx Reports Fourth Quarter and Calendar 2011 Results
12:00am
6-K
EX-99
4pzxjtnyq
7 Mar 12
BioLineRx Announces Grant of European Patent Covering
12:00am
6-K
EX-99
to8uvcsi q89tsrz9sr
5 Mar 12
BioLineRx Receives Approval for Commencing
12:00am
6-K
EX-99
wahjoroxlypm3eva
6 Feb 12
Current report (foreign)
12:00am
6-K
EX-99
xejdafjjg1n63u3muz5p
23 Jan 12
BioLineRx Signs Exclusive License Agreement
12:00am
6-K
EX-99
6jq8wdlrgv6m28n tty
13 Dec 11
BioLineRx to Develop and Commercialize Novel Peptide
12:00am
6-K
EX-99
i70rrbil5hik
5 Dec 11
BioLineRx Announces Positive Final Results from Phase Ia
12:00am
6-K
EX-1
3rbuj3ueatsk
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
6-K
EX-1
4xho1vw8ctlssm
26 Sep 11
BioLineRx to Present Data from the Successfully Completed
12:00am
6-K
EX-1
aetb0egv yo
12 Sep 11
BioLineRx Announces Positive Preliminary Results from
12:00am
6-K
EX-1
b801k
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
6-K
EX-2
6ntq hp7p8a4
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
S-8
cnoha ruj9luwfmk
22 Aug 11
Registration of securities for employees
12:00am
20FR12B/A
cdrq8p9gaz52t4l7
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
qkau7x38
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
r0hvl5
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
1c16o4o6ryzvnraxkbu
24 Sep 10
Registration statement (foreign)
12:00am